United States Antivenom Market by Manufacturers, States, Type and Application, Forecast to 2022
Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are only recommended if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.
Scope of the Report:
This report focuses on the Antivenom in United States market, to split the market based on manufacturers, states, type and application.
Market Segment by Manufacturers, this report covers
Merck & Co., Inc.
Haffkine Bio-Pharmaceutical Corporation
Rare Disease Therapeutics
Bharat Serums and Vaccines
Market Segment by States, covering
Market Segment by Type, covers
Market Segment by Applications, can be divided into
There are 17 Chapters to deeply display the United States Antivenom market.
Chapter 1, to describe Antivenom Introduction, product type and application, market overview, market analysis by States, market opportunities, market risk, market driving force;
Chapter 2, to analyze the manufacturers of Antivenom, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the United States market by States, covering California, New York, Texas, Illinois and Florida, with sales, price, revenue and market share of Antivenom, for each state, from 2012 to 2017;
Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;
Chapter 7, 8, 9, 10 and 11, to analyze the key States by Type and Application, covering California, New York, Texas, Illinois and Florida, with sales, revenue and market share by types and applications;
Chapter 12, Antivenom market forecast, by States, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022;
Chapter 13, to analyze the manufacturing cost, key raw materials and manufacturing process etc.
Chapter 14, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);
Chapter 15, to describe sales channel, distributors, traders, dealers etc.
Chapter 16 and 17, to describe Antivenom Research Findings and Conclusion, Appendix, methodology and data source.